Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Jan;14(1):10-4.
doi: 10.1111/j.1601-0825.2007.01419.x.

Hepatitis C: a clinical review

A A Modi  1 , T J Liang
Affiliations
Review

Hepatitis C: a clinical review

A A Modi et al. Oral Dis. 2008 Jan.

Abstract

Hepatitis C is a major cause of chronic liver disease. It has been recognized as a global health problem because of the progression to cirrhosis and hepatocellular cancer. Chronic hepatitis C is usually asymptomatic but can cause considerable liver damage before its recognition. This review discusses the natural history, clinical features, diagnosis, therapy, treatment responses and the side effects associated with the treatment of hepatitis C.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Progress in therapy of hepatitis C. IFN, interferon; PegIFN, peginterferon; R, ribavirin; R low, low-dose ribavirin; R std, standard-dose ribavirin
See this image and copyright information in PMC

References

    1. Alberti A, Boccato S, Vario A, Benvegnu L. Therapy of acute hepatitis C. Hepatology. 2002;36(5 Suppl 1):S195–S200. - PubMed
    1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556–562. - PubMed
    1. Bacon BR. Treatment of patients with hepatitis C and normal serum aminotransferase levels. Hepatology. 2002;36(5 Suppl 1):S179–S184. - PubMed
    1. Davis GL. Monitoring of viral levels during therapy of hepatitis C. Hepatology. 2002;36(5 Suppl 1):S145–S151. - PubMed
    1. Di Bisceglie AM. Natural history of hepatitis C: its impact on clinical management. Hepatology. 2000;31:1014–1018. - PubMed

MeSH terms